Stage IV breast cancer: a population‐based study about prognostic factors according to HER2 and HR status

E-ISSN： 1365-2354|24|6|920-928

ISSN： 0961-5423

Source： EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol.24, Iss.6, 2015-11, pp. : 920-928

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced-Stage (FIGO III–IV) Epithelial Ovarian Cancer: Multivariate Analysis of Prognostic Factors in an Area without a Tertiary Referral Oncology Center. A Population-Based Study

Oncology Research and Treatment, Vol. 22, Iss. 5, 1999-11 ,pp. : 406-410

Karger

Access to resources Recommend Favorite

Factors Influencing the Hormone Receptor and HER2 Levels in Breast Cancer: A Population-Based Analysis

Oncology Research and Treatment, Vol. 35, Iss. 3, 2012-02 ,pp. : 95-98

Karger

Access to resources Recommend Favorite

Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab

Oncology Research and Treatment, Vol. 36, Iss. 10, 2013-09 ,pp. : 554-558

Karger

Access to resources Recommend Favorite

Population-Based Patient Care Study for Breast Cancer

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-05 ,pp. : 168-173

Karger

Access to resources Recommend Favorite

HER2: The Neu Prognostic Marker for Breast Cancer

By Tsongalis Gregory J. Ricci Jr. Andrew

Critical Reviews in Clinical Laboratory Sciences, Vol. 38, Iss. 2, 1998-03 ,pp. : 167-182

Informa Healthcare

Access to resources Recommend Favorite